Efficacy and safety of cefepime treatment in Chinese patients with severe bacterial infections: in comparison with ceftazidime treatment
- 1 August 1998
- journal article
- clinical trial
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 10 (3) , 245-248
- https://doi.org/10.1016/s0924-8579(98)00040-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cefepime: overview of activity in vitro and in vivoJournal of Antimicrobial Chemotherapy, 1993
- In-vitro antibacterial activity of cefepime: a multicentre studyJournal of Antimicrobial Chemotherapy, 1993
- In-vitro activity of cefepime and other antimicrobials: Survey of European isolatesJournal of Antimicrobial Chemotherapy, 1993
- In-vitro activities of cefepime against Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa and other aerobic Gram-negative bacilliJournal of Antimicrobial Chemotherapy, 1993
- International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infectionsJournal of Antimicrobial Chemotherapy, 1993
- A comparative study of cefepime and ceftazidime in the treatment of community-acquired lower respiratory tract infectionsJournal of Antimicrobial Chemotherapy, 1993
- A non-comparative, multicentre study of cefepime in the treatment of serious bacterial infectionsJournal of Antimicrobial Chemotherapy, 1993
- Low-dosage cefepime as treatment for serious bacterial infectionsJournal of Antimicrobial Chemotherapy, 1993
- Open trial of cefepime (BMY 28142) for infections in hospitalized patientsAntimicrobial Agents and Chemotherapy, 1990
- The use of cefepime (BMY 28142) to treat respiratory infectionsDiagnostic Microbiology and Infectious Disease, 1989